NRF nabs M&A partner from PwC
Global law firm Norton Rose Fulbright has welcomed a big four corporate M&A partner in Sydney.
Bryan Pointon will join the firm’s corporate M&A practice in Sydney on 1 October.
“Bryan’s stellar reputation precedes him. His career has been marked by a series of influential roles that helped strengthen client relationships and win significant new matters in Australia and the broader Asia-Pacific region, and his leadership qualities and experience will add significant capability and depth to our corporate M&A practice,” Norton Rose Fulbright managing partner in Australia, Alison Deitz, said on the move.
“We are delighted that our clients will be able to benefit from the breadth of Bryan’s experience advising on some of the most noteworthy corporate M&A, private equity and government transactions in the market.”
A previous partner at PwC Legal, Mr Pointon is a senior practitioner with a wealth of experience in the health; technology, media and telecommunications; food and beverage; and agribusiness sectors.
His client list includes global PE buyout firm The Carlyle Group and local firm Colinton Capital Partners.
Across his diverse career he has advised on public law litigation, US securities (having previously been admitted to practise in New York), telecommunications and media, corporate M&A and private equity matters. He has also advised on complex government transactions and privatisations.
“Australia, along with the rest of the world, is about to embark on a difficult period of rising distressed M&A activity that will eventually give way to the kind of dealmaking that comes with economic revival and growth,” Mr Pointon commented on his move.
“Over that time, clients will need trusted advisers that can bring a combination of domestic scale and genuinely global reach, capability and insight.”
Mr Pointon said Norton Rose Fulbright has all of those ingredients and is perfectly placed to assist companies and governments to “manage risk and pursue new opportunities flowing from the COVID-19 pandemic.”